Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis

Adam Ceroi, David Masson, Anne Roggy, Christophe Roumier, Cécile Chagué, Thierry Gauthier, Laure Philippe, Baptiste Lamarthée, Fanny Angelot-Delettre, Francis Bonnefoy, Sylvain Perruche, Sabeha Biichle, Claude Preudhomme, Elisabeth Macintyre, Laurent Lagrost, Francine Garnache-Ottou, Philippe Saas

Blood (2016) 128 (23): 2694–2707.

https://doi.org/10.1182/blood-2016-06-724807

Published: 2016

Includes: Supplemental data

Journal Articles

High Response Rate After 4 Courses of R-DHAP In Untreated Mantle Cell Lymphoma (MCL) Patients In the Ongoing Phase III Randomized GOELAMS and GELA LyMa Trial

Blood (2010) 116 (21): 1758.

https://doi.org/10.1182/blood.V116.21.1758.1758

Published: 2010

Journal Articles

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

Jacques Delaunay, MD, Raouf Ben Abdelali, MD, Cyrille Touzeau, MD, Patrice Chevallier, MD, Guillaume Thierry, MD, Steven Le Gouill, MD, PhD, Sameh Ayari, MD, Jean-Luc Harousseau, MD, Elisabeth Macintyre, MD, PhD, Herve Avet Loiseau, MD, PhD, Herve Dombret, MD, Pascaline Talmant, MD

Blood (2007) 110 (11): 4329.

https://doi.org/10.1182/blood.V110.11.4329.4329

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Blood (2007) 110 (11): 3169.

https://doi.org/10.1182/blood.V110.11.3169.3169

Published: 2007

Journal Articles

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Christophe Roumier, MD, Olivier Nibourel, MD, John Devos, PHD, Pacale Cornillet-Lefebvre, MD, Sylvia Merk, PHD, Hervé Dombret, MD-PHD, Norbert Ifrah, MD-PHD, Elisabeth Macintyre, MD-PHD, Marie-Christine Bene, MD-PHD, Jean-Pierre Kerckaert, PHD, Torsten Haferlach, MD-PHD, Claude Preudhomme, PD-PHD

Blood (2007) 110 (11): 3481.

https://doi.org/10.1182/blood.V110.11.3481.3481

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Blood (2006) 108 (11): 103.

https://doi.org/10.1182/blood.V108.11.103.103

Published: 2006

Journal Articles

Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas

Sidonie Niclot, Quentin Pruvot, Caroline Besson, Daniel Savoy, Elisabeth Macintyre, Gilles Salles, Nicole Brousse, Bruno Varet, Paul Landais, Pierre Taupin, Claudine Junien, Dominique Baudry-Bluteau

Blood (2006) 108 (1): 278–285.

https://doi.org/10.1182/blood-2005-04-1567

Published: 2006

Journal Articles

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Torsten Haferlach, MD, Alexander Kohlmann, PhD, Guiseppe Basso, PhD, Marie-Christine Bene, PhD, James R. Downing, PhD, Jesus M. Hernandez, MD, Wolf-Karsten Hofmann, MD, Thomas J. Kipps, PhD, Truus te Kronnie, PhD, Wei-Min Liu, Sunhee Ro, Elisabeth MacIntyre, PhD, Ken I. Mills, PhD, Claude Preudhomme, PhD, Laura Z. Rassenti, PhD, John de Vos, PhD, Mickey Williams, PhD, Lothar Wieczorek, Robin Foa, PhD

Blood (2005) 106 (11): 757.

https://doi.org/10.1182/blood.V106.11.757.757

Published: 2005

Journal Articles

Evaluation of Minimal Residual Disease (MRD) by Quantification of TEL-AML1 Transcripts Is a Powerful Prognostic Tool in Children with T(12;21) Positive Acute Lymphoblastic Leukemia (ALL).

Blood (2004) 104 (11): 322.

https://doi.org/10.1182/blood.V104.11.322.322

Published: 2004

Journal Articles

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Blood (2004) 104 (11): 1105.

https://doi.org/10.1182/blood.V104.11.1105.1105

Published: 2004

Journal Articles

Is Complicated Celiac Disease or Refractory Sprue an Intestinal Intra-Epithelial Cryptic T-Cell Lymphoma?

Nicole Brousse, Virginie Verkarre, Natacha Patey-Mariaud de Serre, Christophe Cellier, Nadine Cerf-Bensussan, Eric Delabesse, Elisabeth Macintyre

Blood (1999) 93 (9): 3154–3155.

https://doi.org/10.1182/blood.V93.9.3154a

Published: 1999

NARROW

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis

High Response Rate After 4 Courses of R-DHAP In Untreated Mantle Cell Lymphoma (MCL) Patients In the Ongoing Phase III Randomized GOELAMS and GELA LyMa Trial

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Evaluation of Minimal Residual Disease (MRD) by Quantification of TEL-AML1 Transcripts Is a Powerful Prognostic Tool in Children with T(12;21) Positive Acute Lymphoblastic Leukemia (ALL).

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Is Complicated Celiac Disease or Refractory Sprue an Intestinal Intra-Epithelial Cryptic T-Cell Lymphoma?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only